Profile data is unavailable for this security.
About the company
CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company is specialized in drug delivery systems technology within the pharmaceutical industry. The Company is focused is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company plans to specialize in the development of oral drug delivery systems for pain management and treatment. Film strip encapsulated with the actives to help in pain reduction can include many combinations to help reduce pain and addiction and help patient safely. Oral Thin strips helps in pain management and inflammation indications, such as Arthritis. The Company has invented an ideal intra oral, fast-dissolving drug delivery system. This novel intraoral drug delivery system is its proprietary patented technology and is a thin, flexible and quick-dissolving film.
- Revenue in USD (TTM)0.00
- Net income in USD-1.67m
- Incorporated1996
- Employees0.00
- LocationCTT Pharmaceutical Holdings Inc3853 Northdale Blvd #268TAMPA 33624United StatesUSA
- Phone+1 (813) 606-0060
- Fax+1 (302) 636-5454
- Websitehttps://www.cttpharmaceuticals.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hi-Great Group Holding Co | 101.27k | -113.56k | 1.78m | -- | -- | -- | -- | 17.58 | -0.0011 | -0.0011 | 0.001 | -0.0011 | 0.7887 | 0.8027 | -- | -- | -88.44 | -- | -- | -- | 48.60 | -- | -112.14 | -- | 0.0197 | -48.81 | -- | -- | -47.32 | -- | -3,789.70 | -- | -- | -- |
| Neximmune Inc | 0.00 | -25.86m | 1.84m | 6.00 | -- | 0.6699 | -- | -- | -24.16 | -24.16 | 0.00 | 2.16 | 0.00 | -- | -- | 0.00 | -130.41 | -115.07 | -183.16 | -165.07 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 48.25 | -- | -44.65 | -- |
| Salarius Pharmaceuticals Inc | 0.00 | -8.92m | 1.90m | 2.00 | -- | 0.4714 | -- | -- | -21.71 | -21.71 | 0.00 | 6.77 | 0.00 | -- | -- | 0.00 | -119.38 | -69.27 | -193.68 | -79.89 | -- | -- | -- | -675.70 | -- | -- | 0.031 | -- | -- | -- | 60.32 | -- | -- | -- |
| Galmed Pharmaceuticals Ltd | 0.00 | -6.36m | 2.00m | 3.00 | -- | 0.1479 | -- | -- | -2.83 | -2.83 | 0.00 | 2.12 | 0.00 | -- | -- | 0.00 | -43.37 | -45.06 | -51.38 | -50.79 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.31 | -- | -- | -- |
| Entero Therapeutics Inc | 0.00 | -6.44m | 2.03m | 15.00 | -- | 0.1026 | -- | -- | -51.90 | -51.90 | 0.00 | 38.45 | 0.00 | -- | -- | 0.00 | -12.74 | -295.92 | -14.01 | -1,599.51 | -- | -- | -- | -- | -- | -265.69 | 0.0802 | -- | -- | -- | -7.55 | -- | -- | -- |
| Phio Pharmaceuticals Corp | 0.00 | -9.38m | 2.03m | 8.00 | -- | 0.3628 | -- | -- | -33.43 | -33.43 | 0.00 | 10.98 | 0.00 | -- | -- | 0.00 | -113.26 | -71.92 | -145.23 | -84.15 | -- | -- | -- | -253,785.70 | -- | -- | 0.00 | -- | -- | -- | 5.70 | -- | 0.00 | -- |
| CTT Pharmaceutical Holdings Inc | 0.00 | -1.67m | 2.11m | 0.00 | -- | 1.18 | -- | -- | -0.0822 | -0.0822 | 0.00 | 0.0346 | 0.00 | -- | -- | -- | -317.28 | 13.49 | -448.83 | 304.48 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3,454.52 | -- | -- | -- |
| 180 Life Sciences Corp | 0.00 | -16.24m | 2.17m | 4.00 | -- | -- | -- | -- | -41.54 | -41.54 | 0.00 | -1.12 | 0.00 | -- | -- | 0.00 | -176.90 | -42.39 | -354.57 | -56.41 | -- | -- | -- | -- | -- | -385.88 | -- | -- | -- | -- | 48.52 | -- | -- | -- |
| PaxMedica Inc | 0.00 | -18.15m | 2.18m | 6.00 | -- | 1.76 | -- | -- | -11.19 | -11.19 | 0.00 | 0.1594 | 0.00 | -- | -- | 0.00 | -474.77 | -755.77 | -781.78 | -- | -- | -- | -- | -- | -- | -3,015.03 | 0.00 | -- | -- | -- | -23.56 | -- | -- | -- |
| Kiromic Biopharma Inc | 0.00 | -25.24m | 2.31m | 35.00 | -- | -- | -- | -- | -21.18 | -21.18 | 0.00 | -5.60 | 0.00 | -- | -- | 0.00 | -169.39 | -161.04 | -- | -294.57 | -- | -- | -- | -- | -- | -8.20 | 2.45 | -- | -- | -- | 33.00 | -- | 8.52 | -- |
| Cyclacel Pharmaceuticals Inc | 449.00k | -19.85m | 2.49m | 12.00 | -- | -- | -- | 5.54 | -21.99 | -21.99 | 0.4636 | -1.67 | 0.0318 | -- | 0.1204 | -- | -139.57 | -57.58 | -314.22 | -69.81 | -- | -- | -4,386.86 | -18,789.29 | -- | -128.51 | -- | -- | -- | 22.87 | -6.34 | -- | -31.23 | -- |
| Qrons Inc | 0.00 | -763.52k | 2.53m | 2.00 | -- | -- | -- | -- | -0.0562 | -0.0562 | 0.00 | -0.1078 | 0.00 | -- | -- | 0.00 | -18,782.78 | -1,513.45 | -- | -- | -- | -- | -- | -- | -- | -19.02 | -- | -- | -- | -- | -7.61 | -- | -- | -- |
